Capsugel® Ι Lonza Pharma & Biotech

-Micronization improves API bioavailability in new chemical entities. -Increased market demand for micronization has sparked increased CMO services. -Lonza Engine™ provides advantages throughout the drug development process.

In this executive summary, experts will present the in vitro dissolution and an in vivo bioequivalence study comparing the performance of the identical formulation of three different drugs in Capsugel® Vcaps® Plus capsules to hard gelatin capsules. In addition, the circumstances under which the same API and formulation contained in HGC and Capsugel® Vcaps® Plus can be expected to provide equivalent performance will be discussed.